+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doxorubicin"

Doxorubicin Market - Global Forecast 2025-2032 - Product Thumbnail Image

Doxorubicin Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 183 Pages
  • Global
From
Doxorubicin Market Report 2025 - Product Thumbnail Image

Doxorubicin Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • December 2025
  • 215 Pages
  • Global
From
From
From
From
Kaposi Sarcoma Market - Global Forecast 2025-2032 - Product Thumbnail Image

Kaposi Sarcoma Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 192 Pages
  • Global
From
Epirubicin Market - Global Forecast 2025-2032 - Product Thumbnail Image

Epirubicin Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
From
From
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
Follicular Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Clear Cell Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Doxorubicin is an oncology drug used to treat a variety of cancers, including leukemia, lymphoma, and breast, ovarian, and bladder cancer. It is a type of anthracycline antibiotic, derived from Streptomyces peucetius, and works by interfering with the growth of cancer cells. It is administered intravenously, and is often used in combination with other drugs. Doxorubicin is one of the most widely used chemotherapy drugs, and is often used in combination with other drugs to treat a variety of cancers. It is also used to treat Kaposi's sarcoma, a type of skin cancer. Side effects of doxorubicin include nausea, vomiting, hair loss, and an increased risk of infection. The doxorubicin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more